Devyser

Devyser company information, Employees & Contact Information

Explore related pages

Related company profiles:

Devyser. A new level of certainty We’re specialists when it comes to diagnostic kits for complex DNA testing within oncology, hereditary diseases and transplantation. Our products are used to guide targeted cancer therapies, to enable rapid prenatal diagnostics, as well as in post transplant follow-up. We have a guiding principle when it comes to developing products that are ideal for routine diagnostics: make the technology simple, reproducible and less prone to user-generated errors. And this is precisely what our customers appreciate about us, which is why routine diagnostic laboratories in more than 60 countries worldwide use our products.
Looking for a particular Devyser employee's phone or email?

Devyser Questions

News

Interpreting immune evasion: a novel assay for HLA loss detection - Frontiers

Interpreting immune evasion: a novel assay for HLA loss detection Frontiers

Companies Like Devyser Diagnostics (STO:DVYSR) Are In A Position To Invest In Growth - simplywall.st

Companies Like Devyser Diagnostics (STO:DVYSR) Are In A Position To Invest In Growth simplywall.st

Devyser to democratize NGS test, seek US FDA approval - BioWorld MedTech

Devyser to democratize NGS test, seek US FDA approval BioWorld MedTech

Earnings call transcript: Devyser Diagnostics Q2 2025 revenue beats forecast - Investing.com

Earnings call transcript: Devyser Diagnostics Q2 2025 revenue beats forecast Investing.com

Invitation to presentation of Devyser’s Q2 2025 Interim Report - TradingView

Invitation to presentation of Devyser’s Q2 2025 Interim Report TradingView

Sweden’s Devyser Takes on U.S. Genetic Testing Market With Atlanta Lab - Global Atlanta

Sweden’s Devyser Takes on U.S. Genetic Testing Market With Atlanta Lab Global Atlanta

Devyser resigns as CEO – board member takes over - Biostock

Devyser resigns as CEO – board member takes over Biostock

Nordea raises target price for Devyser to SEK 140 (125), reiterates Buy - MarketScreener

Nordea raises target price for Devyser to SEK 140 (125), reiterates Buy MarketScreener

Redeye: Devyser Q2 - Profitable from here on - TradingView

Redeye: Devyser Q2 - Profitable from here on TradingView

Top Devyser Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant